Preimplantation Genetic Screening (胚胎植入前遺傳篩選): An Overview of Embryo Evaluation

Wiki Article

Preimplantation genetic screening (胚胎植入前遺傳篩選) is a reproductive technology used to evaluate embryos created through IVF before they are placed into the uterus. The purpose of this approach is to examine genetic information related to chromosome status and assist in selecting embryos with suitable characteristics for transfer.

Historically, the term “preimplantation genetic screening” was commonly used to describe chromosome evaluation in embryos. Modern reproductive medicine often uses the broader term preimplantation genetic testing (PGT), which includes different types of genetic assessments depending on the purpose of testing.

The procedure begins with IVF treatment, where eggs and sperm are combined in a laboratory to create embryos. After embryos reach an appropriate developmental stage, specialists collect a small sample of cells for genetic analysis while maintaining embryo preservation.

Embryo screening may help identify certain chromosome abnormalities that could affect implantation, pregnancy development, or miscarriage risk. It may be considered for individuals with specific fertility challenges, although its suitability depends on medical evaluation.

The information obtained from preimplantation genetic screening can support discussions between patients and fertility specialists. Decisions regarding embryo transfer consider multiple factors, including genetic results, embryo development, patient health, and reproductive goals.

Preimplantation genetic screening represents the connection between reproductive medicine and genetic science 胚胎植入前遺傳篩選. As testing methods continue to improve, embryo evaluation technologies continue to evolve as part of personalized fertility treatment.